PubRank

BRCA1 and BRCA2 mutations in ovarian cancer patients from China: ethnic-related mutations in BRCA1 associated with an increased risk of ovarian cancer.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 28176296)

Published in Int J Cancer on February 23, 2017

Authors

Tingyan Shi1, Pan Wang1, Caixia Xie2, Sheng Yin1, Di Shi1, Congchong Wei2, Wenbin Tang1, Rong Jiang1, Xi Cheng3, Qingyi Wei4,5, Qing Wang6, Rongyu Zang7

Author Affiliations

1: Ovarian Cancer Program, Division of Gynecologic Oncology, Department of Gynecology & Obstetrics, Zhongshan hospital, Fudan University, Shanghai, 200032, China.
2: Shanghai Topgen Bio-Pharm Co, Ltd, Shanghai, China.
3: Gynecologic Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.
4: Cancer Institute, Fudan University Shanghai Cancer Center, Shanghai, China.
5: Duke Cancer Institute, Duke University Medical Center, Durham, NC.
6: Plateforme de génomique des cancers, Centre Léon Bérard, Laboratoire de la génétique constitutionnelle HCL-CLB, Lyon, France.
7: Department of Obstetrics and Gynecology, Zhongshan Hospital, Fudan University, Shanghai, China. ryzang@yahoo.com.

Articles by these authors ⇆

Associations between RNA splicing regulatory variants of stemness-related genes and racial disparities in susceptibility to prostate cancer. Int J Cancer (2017) 0.75

Significant association of the EXO1 rs851797 polymorphism with clinical outcome of ovarian cancer. Onco Targets Ther (2017) 0.75

The 5th Shanghai Gynecologic Oncology Group (SGOG)-Korean Gynecologic Oncology Group (KGOG) joint meeting and 2016 Asia-Pacific Ovarian cancer Laparotomy and Laparoscopic Operation (APOLLO) symposium in Shanghai. J Gynecol Oncol (2016) 0.75

Genetic Variants in the Genes Encoding Rho GTPases and Related Regulators Predict Cutaneous Melanoma-specific Survival. Int J Cancer (2017) 0.75

A PGC1β genetic variant associated with nevus count and melanoma mortality. Int J Cancer (2017) 0.75